Curanex Pharmaceuticals Inc Common Stock (CURX) vs Mangoceuticals, Inc. (MGRX)
A side-by-side comparison of Curanex Pharmaceuticals Inc Common Stock and Mangoceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CURX
Curanex Pharmaceuticals Inc Common Stock
$5.10HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
MGRX
Mangoceuticals, Inc.
$0.41HealthcareDelayed quote: Oct 6, 2026, 10:48 AM EDT
Total return — CURX vs MGRX
growth of $100 · dividends reinvested · last 1yCURX -93.8% (-93.8%/yr)MGRX -77.6% (-77.6%/yr)MGRX compounded faster over this window
CURX MGRX
CURX vs MGRX: by the numbers
- •CURX is the larger company ($7M vs $7M market cap).
- •Both run net losses; CURX's is the smaller (0.00% vs -4791.48% net margin).
Metrics side by side
Valuation
| Metric | CURX | MGRX |
|---|---|---|
| P/S ratio | N/A | 22.23 |
| P/B ratio | 1.51 | 0.56 |
Profitability
| Metric | CURX | MGRX |
|---|---|---|
| Gross margin | 0.00% | 54.43% |
| Operating margin | 0.00% | -4200.46% |
| Net margin | 0.00% | -4791.48% |
| ROE | -218.65% | -120.58% |
| ROIC | -208.39% | -102.91% |
Go deeper
Dig into the metrics
Curanex Pharmaceuticals Inc Common Stock ROEMangoceuticals ROECuranex Pharmaceuticals Inc Common Stock operating marginMangoceuticals operating marginCuranex Pharmaceuticals Inc Common Stock revenue growthMangoceuticals revenue growthCuranex Pharmaceuticals Inc Common Stock free cash flowMangoceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.